[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@3primeAnalytica Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1372950951175278595.png) @3primeAnalytica 3PrimeAnalytica

3PrimeAnalytica posts on X about $beam, $edit, $arkq, $prme the most. They currently have XXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1372950951175278595/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1372950951175278595/c:line/m:interactions.svg)

- X Week XXXXX -XXXX%
- X Month XXXXXX -XXXX%
- X Months XXXXXXX +492,305%
- X Year XXXXXXX +2,570%

### Mentions: X [#](/creator/twitter::1372950951175278595/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1372950951175278595/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX +6.70%
- X Months XXX +16,100%
- X Year XXX +1,258%

### Followers: XXXXX [#](/creator/twitter::1372950951175278595/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1372950951175278595/c:line/m:followers.svg)

- X Week XXXXX +1.20%
- X Month XXXXX +11%
- X Months XXXXX +38%
- X Year XXXXX +36%

### CreatorRank: undefined [#](/creator/twitter::1372950951175278595/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1372950951175278595/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1372950951175278595/influence)
---

**Social category influence**
[cryptocurrencies](/list/cryptocurrencies)  XXXX% [finance](/list/finance)  XXXX% [stocks](/list/stocks)  XXXX% [technology brands](/list/technology-brands)  XXXX% [currencies](/list/currencies)  XXXX%

**Social topic influence**
[$beam](/topic/$beam) 9.76%, [$edit](/topic/$edit) #8, [$arkq](/topic/$arkq) 4.88%, [$prme](/topic/$prme) 4.88%, [$crsp](/topic/$crsp) 4.88%, [$ntla](/topic/$ntla) 4.88%, [$sana](/topic/$sana) 4.88%, [$crbu](/topic/$crbu) 4.88%, [crispr](/topic/crispr) 4.88%, [$pfe](/topic/$pfe) XXXX%

**Top accounts mentioned or mentioned by**
[@geneinvesting](/creator/undefined) [@crisprtx](/creator/undefined) [@zhaoweiasu](/creator/undefined) [@jawnzilla](/creator/undefined) [@vegan1](/creator/undefined) [@intelliatx](/creator/undefined) [@rolandoamoreno](/creator/undefined) [@biotech2k1](/creator/undefined) [@vega_n1](/creator/undefined) [@primemedicine](/creator/undefined) [@beamtx](/creator/undefined) [@astrazeneca](/creator/undefined) [@arpah](/creator/undefined) [@oliverventure](/creator/undefined) [@thechartlife](/creator/undefined) [@matthughes13](/creator/undefined) [@arkkdaily](/creator/undefined) [@neo8634](/creator/undefined) [@sguiderna](/creator/undefined)

**Top assets mentioned**
[BEAM (BEAM)](/topic/$beam) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [Pfizer, Inc. (PFE)](/topic/$pfe) [Ethereum (ETH)](/topic/$eth) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [AstraZeneca PLC (AZN)](/topic/$azn) [GSK plc (GSK)](/topic/$gsk)
### Top Social Posts [#](/creator/twitter::1372950951175278595/posts)
---
Top posts by engagements in the last XX hours

"@jawnzilla @VEGA_n1 good times ahead i think"  
[X Link](https://x.com/3primeAnalytica/status/1977038357663449486) [@3primeAnalytica](/creator/x/3primeAnalytica) 2025-10-11T15:47Z 1272 followers, XX engagements


"last qtr movements: fully exited $PFE (thx for the divyys a good piggy bank while it lasted) exited a small fund (chg. in mgmt). Reduced: $ARKQ (though that shows no signs of stopping). Increased: $BEAM $ETH $ARKG $REGN"  
[X Link](https://x.com/3primeAnalytica/status/1974828650957508663) [@3primeAnalytica](/creator/x/3primeAnalytica) 2025-10-05T13:26Z 1272 followers, XXX engagements


"Here's your Morning CRISPR Brief ☕☀ Recap: $PRME led gains +19.32% followed by $CRSP +10% $EDIT +9.58% $NTLA +8.96% $SANA +7.30% $BEAM +6% while $CRBU declined -1.33%. - Yesterdays session was absolutely EPIC 🔥 with the rally sustained across these CRISPR names (except CRBU) signalling strong investor confidence in the sector's momentum. - @PrimeMedicine surged back $1bn mc bolstering its positioning after this stellar rebound. This milestone could be key as many institutional funds have minimum mc thresholds that previously restricted participation; now likely to pile in if they see"  
[X Link](https://x.com/3primeAnalytica/status/1974099746332545092) [@3primeAnalytica](/creator/x/3primeAnalytica) 2025-10-03T13:10Z 1272 followers, 2020 engagements


"Here's your Morning CRISPR Brief ☕☀ Recap: gene editing stocks dipped 3-9% on Oct. 10th amid broader market weakness but fundamentals remain intact $CRSP -XXXX% $SANA -XXXX% $NTLA -XXXX% $BEAM -XXXX% $EDIT -XXXX% $PRME -XXXX% $CRBU -9.45%. Big Pharmas interest in CRISPR is heating up again 🔥 as evidenced by several partnerships and deals just last week. The unveiling of a next-gen platform like SyNTase and good poc data reflects steady momentum in the gene editing sector. Some highlights from last week: 1) Non-dilutive win for @BeamTx: $BMY acquired Orbital Therapeutics BEAM's RNA"  
[X Link](https://x.com/3primeAnalytica/status/1977725387820954040) [@3primeAnalytica](/creator/x/3primeAnalytica) 2025-10-13T13:17Z 1273 followers, 2897 engagements


"Overnight looking good so far 👍🏼only bought a tiny bit of $BEAM last Friday though"  
[X Link](https://x.com/3primeAnalytica/status/1977532290528842215) [@3primeAnalytica](/creator/x/3primeAnalytica) 2025-10-13T00:30Z 1272 followers, 1731 engagements


"Ladies & gents the Jim Cramer of Biotech strikes again 🤡"  
[X Link](https://x.com/3primeAnalytica/status/1976706720333213726) [@3primeAnalytica](/creator/x/3primeAnalytica) 2025-10-10T17:49Z 1271 followers, 1612 engagements


"$EDIT still a name I won't touch but I know many people are still in it likely just trading it.+184% YTD (went $X in Apr.).still not bad at all for those who traded it this year or who for some reason started investing in it this yr well done I guess. They presented good preclinic in vivo poc data for EDIT-401 last Thursday.mkt didn't care on the 9th definitely not on the 10th either.still progress.still won't touch"  
[X Link](https://x.com/3primeAnalytica/status/1977425295444500974) [@3primeAnalytica](/creator/x/3primeAnalytica) 2025-10-12T17:25Z 1271 followers, 1240 engagements


"FDA slapped Regenxbio with a 3-month delay on RGX-121 for Hunter syndrome - 'more data' is the favourite excuse 🙄. FDA delays continue to pile up = biotech dreams crushed again. $RGNX #FDAFail #Biotech #GeneTherapy 🔥"  
[X Link](https://x.com/3primeAnalytica/status/1958119699918594469) [@3primeAnalytica](/creator/x/3primeAnalytica) 2025-08-20T10:51Z 1271 followers, XXX engagements


"@RolandoAMoreno pole position in my $CIBR 💪been a good source of steady gains/anchor last few years"  
[X Link](https://x.com/3primeAnalytica/status/1978860057845440525) [@3primeAnalytica](/creator/x/3primeAnalytica) 2025-10-16T16:26Z 1271 followers, XXX engagements


"@_OliverVenture 🔥🔥now superimpose $ARKQ $ARKW $ARKF 😁"  
[X Link](https://x.com/3primeAnalytica/status/1977530046761123889) [@3primeAnalytica](/creator/x/3primeAnalytica) 2025-10-13T00:21Z 1271 followers, XXX engagements


"🚨 CRISPR News 🧬: AstraZeneca $AZN seals a $555m deal with Algen Biotechnologies for exclusive rights to AI-powered CRISPR therapies targeting immune disorders and cancer - underscoring the tech's accelerating potential to transform DD & spark investor interest. CRISPR's future keeps shining 🚀"  
[X Link](https://x.com/3primeAnalytica/status/1975225660206469311) [@3primeAnalytica](/creator/x/3primeAnalytica) 2025-10-06T15:44Z 1272 followers, 3512 engagements


"$WVE released positive interim results for its RNA-editing therapy WVE-006 primarily developed under a partnership with $GSK which holds the global license and will assume full responsibility post-trial. The data indicate comparable total alpha-1 antitrypsin (AAT) levels to those reported in $BEAM's - XXX program with both achieving approximately 1112 M. However BEAM-302 demonstrates higher relative production of functional M-AAT (91% of total AAT) and a greater reduction in pathogenic Z-AAT (79%) compared to WVE-006 (64% M-AAT and XX% Z-AAT reduction). Waves data does seem to validate"  
[X Link](https://x.com/3primeAnalytica/status/1963235994800365826) [@3primeAnalytica](/creator/x/3primeAnalytica) 2025-09-03T13:41Z 1272 followers, 1399 engagements


"Many wonderful patient stories are accumulating and surely more to come: ✅ Baby Tomas at UKs GOSH XX months old with OTC deficiency received gene editing last summer and is now off steroids special diets and meds. ✅ Alyssa also at UKs GOSH with incurable T-cell leukemia received the worlds first base-edited CAR-T cells in May 2022; now cancer-free and back home"  
[X Link](https://x.com/3primeAnalytica/status/1977493335498453348) [@3primeAnalytica](/creator/x/3primeAnalytica) 2025-10-12T21:55Z 1273 followers, XXX engagements